36 results match your criteria: "centre hospitalo-universitaire Grenoble Alpes[Affiliation]"
Rev Infirm
August 2024
Université Grenoble Alpes, Pôle Pharmacie, Centre hospitalo-universitaire Grenoble Alpes, 38700 La Tronche, France; Université Grenoble Alpes, CNRS, TIMC, UMR 5525, Centre hospitalo-universitaire Grenoble Alpes, 38700 La Tronche, France.
Rev Infirm
May 2024
Université Grenoble Alpes, Pôle pharmacie, Centre hospitalo-universitaire Grenoble Alpes, Grenoble, France; Université Grenoble Alpes, CNRS, Pôle pharmacie, TIMC, UMR5525, Centre hospitalo-universitaire Grenoble Alpes, France.
Eur Ann Otorhinolaryngol Head Neck Dis
September 2024
Service d'oto-rhino-laryngologie et de chirurgie cervicofaciale, Centre hospitalo-universitaire Grenoble Alpes, BP 217, 38043 Grenoble cedex 09, France; BrainTech Lab INSERM UMR 2015, Grenoble, France; GeodAIsics, Grenoble, France; Faculté de médecine, Université Grenoble Alpes, Domaine de la Merci, BP 170 La Tronche, 38042 Grenoble cedex 9, France. Electronic address:
Introduction: Middle-ear adenoma is a rare benign endocrine tumor with slow progression, and can, in very rare cases, lead to recurrent peripheral facial palsy.
Case Report: A young man experienced three episodes of right peripheral facial palsy of incremental intensity, suggestive of barotrauma. CT and MRI found a tissue mass in the tympanic cavity, and biopsy diagnosed middle-ear adenoma.
Rev Infirm
January 2024
Université Grenoble Alpes, Pôle Pharmacie, Centre Hospitalo-Universitaire Grenoble Alpes, 38700 La Tronche, France; Université Grenoble Alpes, CNRS, Pôle pharmacie, TIMC, UMR5525, Centre Hospitalo-Universitaire Grenoble Alpes, 38700 La Tronche, France.
Methods Mol Biol
November 2023
Institut National de la Santé et de la Recherche Médicale, Inserm U1292, Biosanté, Grenoble, France.
J Med Internet Res
May 2023
Translational Innovation in Medicine and Complexity - Unité Mixte de Recherche 5525, Université Grenoble Alpes, Grenoble, France.
Background: European national disparities in the integration of data linkage (ie, being able to match patient data between databases) into routine public health activities were recently highlighted. In France, the claims database covers almost the whole population from birth to death, offering a great research potential for data linkage. As the use of a common unique identifier to directly link personal data is often limited, linkage with a set of indirect key identifiers has been developed, which is associated with the linkage quality challenge to minimize errors in linked data.
View Article and Find Full Text PDFCells
March 2023
Institut National de la Santé et de la Recherche Médicale U1292, Biologie et Biotechnologie pour la Santé, 38043 Grenoble, France.
Int J Mol Sci
January 2023
PDC*line Pharma, 38000 Grenoble, France.
The purpose of immune checkpoint inhibitor (ICI)-based therapies is to help the patient's immune system to combat tumors by restoring the immune response mediated by CD8+ cytotoxic T cells. Despite impressive clinical responses, most patients do not respond to ICIs. Therapeutic vaccines with autologous professional antigen-presenting cells, including dendritic cells, do not show yet significant clinical benefit.
View Article and Find Full Text PDFOrthop Traumatol Surg Res
February 2023
Centre Hospitalo-Universitaire Grenoble Alpes, Hôpital Couple-Enfant, Centre Alpin de la Scoliose, Service d'orthopédie Pédiatrique, CS 10217, 38043 Grenoble Cedex 09, France. Electronic address:
Malformations of the cervical spine are a challenge in pediatric orthopedic surgery since the treatment options are limited. These congenital anomalies are often syndrome-related and have multiple repercussions on the function and statics of the cervical spine in all three planes. They are related to developmental abnormalities during the somite segmentation that occurs during the third week of embryonic development.
View Article and Find Full Text PDFEur J Anaesthesiol
June 2022
From the Division of Anaesthesiology, Intensive Care, Pain and Emergency Medicine, Department of Intensive Care Medicine, Nîmes University Hospital, Nîmes (CR, SL, BL), Equipe d'accueil 2992 Caractéristiques Féminines des Interfaces Vasculaires (IMAGINE), Faculté de médecine, Univ Montpellier, Montpellier (CR, BL), Department of Anesthesiology and Critical Care, Centre Hospitalier Universitaire Lille, Surgical Critical Care, F-59000 Lille (DG), Department of Anaesthesiology and Intensive Care, UNAM University, University of Angers, Angers University Hospital, 49933 Angers (GB), Department of Anesthesia and Critical Care Medicine, Centre Hospitalier Universitaire Amiens Picardie and SSPC Research Unit, Université de Picardie Jules Verne, Amiens (HD), Université Grenoble Alpes, Pôle Anesthésie-Réanimation, Centre Hospitalo-Universitaire Grenoble-Alpes, Grenoble (PB), Service d'anesthésie et des réanimations chirurgicales, Unité de réanimation chirurgicale et neuro-traumatologique, Assistance Publique - Hôpitaux de Paris, Hôpitaux universitaires Henri Mondor, 94000 Créteil (JB), Pôle d'Anesthésie-Réanimation & Médecine Péri-Opératoire, Service d'Anesthésie-Réanimation & Médecine Péri-Opératoire, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France - EA3072, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Faculté de Médecine, Université de Strasbourg, Strasbourg (JP), Université de Paris, INSERM U1152, ANR-10-LABX-17, CHU Bichat-Claude Bernard, APHP, Paris (PM), Département de Médecine d'Urgence, Hôpital de la Timone - AP-HM, Aix Marseille Université, UMR 1263 C2VN, Marseille (PM), CHU Estaing, University of Auvergne, Clermont-Ferrand (SP), Service d'Accueil des Urgences, Hôpital d'Instruction des Armées Percy, Clamart (KA), Hospices Civils de Lyon, centre hospitalier Lyon Sud, service d'Anesthésie-Réanimation, Lyon (PI) and Department of Anaesthesiology and Critical Care, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Saclay, Le Kremlin Bicêtre, France (AH).
Cells
April 2022
Department of Pharmacology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC 3800, Australia.
Biomedicines
January 2022
Institut National de la Santé et de la Recherche Médicale U1292, Biologie et Biotechnologie pour la Santé, 38054 Grenoble, France.
Eur J Med Genet
March 2022
Department of Medical Genetics, Member of ERN-EpiCARE, HFME, University Hospitals of Lyon (HCL), Claude Bernard Lyon1 University, Lyon, France. Electronic address:
Arch Gynecol Obstet
August 2022
Department of Gynecology and Obstetrics, Centre Hospitalier Universitaire de Saint-Étienne, 42055, Saint-Étienne, France.
Purpose: To compare the rate of vaginal birth between double-balloon catheter and oxytocin alone for induction of labor in women with one previous cesarean section and an unfavorable cervix.
Materials And Methods: A retrospective and observational study was conducted from 2013 to 2017, at the Saint-Etienne University Hospital where women received induction with a double-balloon catheter for 12 h and at the Grenoble Alpes University Hospital where women received induction with a low-dose oxytocin infusion. Primary outcome was the rate of vaginal birth.
Biomedicines
October 2021
French Center for Trophoblastic Diseases, University Hospital Lyon Sud, 165 Chemin du Grand Revoyet, 69495 Pierre Bénite, France.
Sci Rep
October 2021
Department of Gynaecology and Obstetrics, Hôpital Nord, University Hospital, Avenue Albert Raimond, 42270, Saint Etienne, France.
Trials
September 2021
Pôle Anesthésie-Réanimation, Centre Hospitalo-Universitaire Grenoble-Alpes, Grenoble, France.
Background: Optimal management of severe trauma patients with active hemorrhage relies on adequate initial resuscitation. Early administration of coagulation factors improves post-traumatic coagulation disorders, and four-factor prothrombin complex concentrate (PCC) might be useful in this context. Our main hypothesis is that four-factor PCC in addition to a massive transfusion protocol decreases blood product consumption at day 1 in severe trauma patients with major bleeding.
View Article and Find Full Text PDFGenet Med
November 2021
Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France.
Microorganisms
June 2021
Translational Innovation in Medicine and Complexity, Centre National de la Recherche Scientifique, Centre Hospitalo-Universitaire Grenoble Alpes, Grenoble Alpes University, 38000 Grenoble, France.
The implementation of MALDI-TOF MS in medical microbiology laboratories has revolutionized practices and significantly reduced turnaround times of identification processes. However, although bacteriology quickly benefited from the contributions of this technique, adjustments were necessary to accommodate the specific characteristics of fungi. MALDI-TOF MS is now an indispensable tool in clinical mycology laboratories, both for the identification of yeasts and filamentous fungi, and other innovative uses are gradually emerging.
View Article and Find Full Text PDFCancers (Basel)
June 2021
Institut National de la Santé et de la Recherche Médicale, Inserm U1292, Université Grenoble-Alpes, 38000 Grenoble, France.
Anaesth Crit Care Pain Med
August 2021
Soins Intensifs, Hôpitaux Universitaires de Genève, Genève, Suisse.
Allergy
October 2021
Department of Otolaryngology, Head and Neck Surgery, Universitätsmedizin Mainz, Mainz, Germany.
Older adults, especially men and/or those with diabetes, hypertension, and/or obesity, are prone to severe COVID-19. In some countries, older adults, particularly those residing in nursing homes, have been prioritized to receive COVID-19 vaccines due to high risk of death. In very rare instances, the COVID-19 vaccines can induce anaphylaxis, and the management of anaphylaxis in older people should be considered carefully.
View Article and Find Full Text PDFBiomedicines
March 2021
Institut National de la Santé et de la Recherche Médicale U1292, Biologie et Biotechnologie pour la Santé, 38000 Grenoble, France.
Infect Dis Now
June 2021
Service des maladies infectieuses, centre hospitalo-universitaire Grenoble Alpes, Grenoble, France, CIC 1406 Inserm, Grenoble, France.
At the end of December 2019, China notified the World Health Organization about a viral pneumonia epidemic soon to be named COVID-19, of which the infectious agent, SARS-CoV-2, was rapidly identified. Less than one year later, published phase 3 clinical trials underlined the effectiveness of vaccines utilizing hitherto unusual technology consisting in injection of the messenger RNA (m-RNA) of a viral protein. In the meantime, numerous clinical trials had failed to identify a maximally effective antiviral treatment, and mass vaccination came to be considered as the strategy most likely to put an end to the pandemic.
View Article and Find Full Text PDFBMC Genomics
November 2020
Univ Rennes, Inria, CNRS, IRISA, Rennes, F-35000, France.
Background: Since 2009, numerous tools have been developed to detect structural variants using short read technologies. Insertions >50 bp are one of the hardest type to discover and are drastically underrepresented in gold standard variant callsets. The advent of long read technologies has completely changed the situation.
View Article and Find Full Text PDF